Medical Equipment Maintenance Market Major Deals and Strategic Alliances Analysis by 2027

Medical Equipment Maintenance Industry Overview

The global medical equipment maintenance market size is expected to reach USD 61.7 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.9% from 2021 to 2027. Rising focus on preventive device maintenance, adoption of advanced funding mechanisms, growth of the associated devices markets, and increasing market share of refurbished medical devices are anticipated to drive the market over the forecast period.

In addition, a surge in the need for technologically advanced medical equipment and an increase in healthcare expenses are expected to propel the market growth. The maintenance of medical devices is a very essential procedure owing to the high use of devices in critical health matters. For instance, calibration is a vital procedure for any medical device to maintain and improve its precision and accuracy, thereby preventing any safety hazards.

Furthermore, increasing global disposable income, rising medical device approvals, and growing adoption of new technologies in emerging countries are projected to further fuel the sales of medical devices, in turn, promoting the maintenance demand. Due to the growing geriatric population, higher expenditure is witnessed for remote patient monitoring devices. And these devices require higher maintenance, which is expected to carry on over the forecast period, thus contributing to the market revenue.

Medical Equipment Maintenance Market Segmentation

Grand View Research has segmented the global medical equipment maintenance market based on equipment, service, and region:

Based on the Equipment Insights, the market is segmented into Imaging Equipment, Electromedical Equipment, Endoscopic Devices, Surgical Instruments, and Other Medical Equipment

• The imaging equipment segment accounted for the largest revenue share of 35.8% in 2020, which includes several devices such as CT, MRI, Digital X-Ray, ultrasound, and others.
• The surgical instruments segment is expected to register the highest CAGR of 8.4% over the forecast period.

Based on the Service Insights, the market is segmented into Preventive Maintenance, Corrective Maintenance, and Operational Maintenance

• The corrective maintenance segment accounted for the largest revenue share of 57.1% in 2020.
• The preventive maintenance segment is anticipated to register the highest CAGR of 8.7% over the forecast period.

Medical Equipment Maintenance Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Companies are adopting partnership as a key strategy to sustain in the highly competitive environment and acquire a greater market share.

Some prominent players in the global Medical Equipment Maintenance market include:

• GE Healthcare
• Siemens Healthineers
• Koninklijke Philips N.V.
• Drägerwerk AG & Co. KGaA
• Medtronic
• Braun Melsungen AG
• Aramark
• BC Technical, Inc.
• Alliance Medical Group
• Althea Group

Order a free sample PDF of the Medical Equipment Maintenance Market Intelligence Study, published by Grand View Research.

Monopolar Electrosurgery Instrument Market Application Outlook, Business Drivers, and Competitive Analysis

Monopolar Electrosurgery Instrument Industry Overview

The global monopolar electrosurgery instrument market size is expected to reach USD 3.0 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.2% from 2021 to 2027. monopolar electrosurgery instrument are majorly used in gynecology and urology procedures to precisely cut and extract tissues. The devices are most commonly used in Laparoscopic Ovarian Drilling (LOD) procedures to manage Polycystic Ovary Syndrome (PCOS). According to the Centers for Disease Control and Prevention (CDC), PCOS is among the major cause of female infertility, affecting 6 - 12% or 5 million U.S. women between the 18-45 age group.

Frequent product launch, increasing prevalence of chronic conditions, and growing preference for minimally invasive procedures have augmented the demand for monopolar electrosurgery devices. For instance, in September 2019, Ethicon, a Johnson and Johnson subsidiary launched a MEGADYNE MEGA SOFT universal plus reusable patient return electrode. The dispersal electrode eliminates adhesive-related injuries and is eco-friendly.

Monopolar Electrosurgery Instrument Market Segmentation

Grand View Research has segmented the global monopolar electrosurgery instrument market based on type, application, end use, and region.

Based on the Type Insights, the market is segmented into Hand Instrument, Generator, Dispersive electrodes, and Accessories

• The hand instrument segment dominated the market for monopolar electrosurgery instrument and accounted for the largest revenue share of 34.1% in 2019.
• The generator segment is expected to register the fastest growth rate over the forecast period. This can be attributed to the increasing reliance of professionals to perform advanced therapeutic procedures and product launches.

Based on the Application Insights, the market is segmented into General surgery, Neurosurgery, Cardiovascular surgery, and Others

• The general surgery segment dominated the market for monopolar electrosurgery instrument and accounted for the largest revenue share of 34.5% in 2019.
• The cardiovascular surgery segment is expected to account for the highest growth rate over the forecast period.

Based on the End-use Insights, the market is segmented into Hospitals, Specialty clinics, and Ambulatory Surgical centers

• The hospital segment dominated the market for monopolar electrosurgery instrument and accounted for the largest revenue share of 40.5% in 2019.
• The ambulatory surgical centers segment dominated the market for monopolar electrosurgery instrument and is expected to register the highest growth rate during the forecast period.

Monopolar Electrosurgery Instrument Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The market for monopolar electrosurgery instrument is highly fragmented with the presence of various large, medium, and small-scale vendors. Product launch, strategic acquisitions, and innovation are the major strategies adopted by the market players to retain their market share.

Some prominent players in the global Monopolar Electrosurgery Instrument market include:

• Conmed
• Olympus Corporation
• Medtronic Plc
• KLS Martin
• Braun Melsungen AG
• Stryker
• Apyx Medical Corporation
• Johnson & Johnson
• Integra LifeSciences
• Stingray Surgical Products, LLC
• Surgical Holdings

Order a free sample PDF of the Monopolar Electrosurgery Instrument Market Intelligence Study, published by Grand View Research.

Single-use Bioprocessing Probes and Sensors Market is Projected to Grow at a CAGR of 13.9% by 2028

Single-use Bioprocessing Probes and Sensors Industry Overview

The global single-use bioprocessing probes and sensors market size is expected to reach USD 5.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.9% from 2021 to 2028. The biopharmaceutical industry is witnessing an increase in the use of single-use technology for the production of biologics, biosimilar, and other biopharmaceutical products. As the need to reduce manufacturing costs is increasing, manufacturers are adopting the implementation of single-use equipment in their production workflow, in turn, boosting revenue growth.

Rising demand for improved bioprocess monitoring devices is another factor driving the market for single-use probes and sensors. Growing biopharmaceutical sector demands advanced sensors to cope with the regulatory norms that require increasingly detailed and complex measurement of processes. Thus, the demand for improved sensors that offer better results is also increasing.

Single-use Bioprocessing Probes and Sensors Market Segmentation

Grand View Research has segmented the global single-use bioprocessing probes and sensors market on the basis of sensor type, workflow, end use, and region:

Based on the Type Insights, the market is segmented into pH Sensor, Oxygen Sensor, Pressure Sensors, Temperature Sensors, Conductivity Sensors, Flow Meters & Sensors, and Others

• Being an integral part of a single-use container, pH sensors held the major revenue share of 20.9% in 2020. High product penetration and usage rate have attributed to this large share.
• The development of disposable sensors that enable users to measure DO separately has driven the segment.

Based on the Workflow Insights, the market is segmented into Upstream and Downstream

• The upstream segment dominated the market for single-use bioprocessing probes and sensors and accounted for the largest revenue share of 74.2% in 2020.
• Downstream segment is expected to witness considerable growth in the coming years due to the constant attempt by operating players to expand the use of disposables in the downstream process.

Based on the End-use Insights, the market is segmented into Biopharmaceutical Manufacturer and Labs & Academic/ Clinical Research Institutes

• The biopharmaceutical manufacturers segment dominated the market for single-use bioprocessing probes and sensors and accounted for a major revenue share of 58.9% in 2020.
• Constant new product developments and accelerated adoption of disposables among contract service providers as well as in-house bio manufacturers to meet the growing global demand for biopharmaceuticals efficiently is one of the major factors for the growth of this segment.

Single-use Bioprocessing Probes and Sensors Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The key players are undertaking various strategic initiatives such as alliances with OEM and new product development with improved technical intricacies to boost their organic revenue growth as well as market presence. OEMs are engaged in obtaining licenses for the incorporation of sensors in their single-use assembly.

Some prominent players in the global Single-use Bioprocessing Probes and Sensors market include:

• Thermo Fisher Scientific
• Sartorius AG
• Danaher Corporation
• PreSens Precision Sensing GmbH
• ABEC
• Hamilton Company
• PendoTECH LLC
• Equflow
• Parker Hannifin Corporation
• Malema Engineering Corporation
• Dover Corporation

Order a free sample PDF of the Single-use Bioprocessing Probes and Sensors Market Intelligence Study, published by Grand View Research.

Flow Diverters Market Growth is driven by Introduction of Technologically Advanced Products, 2028

Flow Diverters Industry Overview

The global flow diverters market size is anticipated to reach USD 874.10 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.9% from 2021 to 2028. Increasing research activities pertaining to the treatment of brain aneurysm and the rising prevalence of cerebral aneurysm are driving the market.

An increasing number of patients suffering from hypertension significantly increases the risk of a brain aneurysm. This is expected to drive market growth in the coming years. Hypertension or trauma to blood vessels is the major cause of brain aneurysm. As per the WHO facts 2019, around 1.1 billion people worldwide are suffering from hypertension.

Flow Diverters Market Segmentation

Grand View Research has segmented the global flow diverters market on the basis of diameter size and region:

Based on the Size Insights, the market is segmented into 2-3 mm Flow Diverters, 3-4 mm Flow Diverters, 4-5 mm Flow Diverters, and >5 mm Flow Diverters

• The >5 mm flow diverters segment dominated the market with a share of 64.50% in 2020 owing to their wide spectrum application in treating large and wide intracranial aneurysms.
• The 3-4 mm flow diverters segment is expected to register the highest CAGR from 2021 to 2028 owing to a rise in the number of product approvals and an increase in the demand for minimally invasive procedures.

Flow Diverters Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Key market players account for a considerable share in the market owing to their broad product offerings. In recent years, flow diverters are getting attention from neurosurgeons owing to their success rate in managing brain aneurysm.

Some prominent players in the global Flow Diverters market include:

• Medtronic
• Stryker Corporation
• MicroVention, Inc. (Terumo Corporation)
• BALT Extrusion SA
• MicroPort Scientific Corporation
• Penumbra Inc.
• Phenox GmbH
• Acandis

Order a free sample PDF of the Flow Diverters Market Intelligence Study, published by Grand View Research.

Key Factors Driving the Laryngeal Mask Market Growth Include Technological Developments

Laryngeal Mask Industry Overview

The global laryngeal mask market size is expected to reach USD 863.7 million by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2021 to 2028. An increase in the number of surgeries that include anesthesia procedures coupled with the rising morbidity related to chronic diseases is the key contributor to market growth.

The key advantages of the product, such as ventilation management during anesthesia, induction, maintenance, and emergence, are anticipated to drive the market. Furthermore, the placement of these masks does not require laryngoscopy and muscle relaxants like succinylcholine, which is known to cause postoperative myalgia in certain patients. Hence, the usage of these masks greatly reduces the incidence of postoperative myalgia.

The COVID-19 pandemic is caused by a coronavirus that is transmitted primarily via droplets, aerosol, or direct contact. This has caused higher infection risk to anesthetists due to their recurrent involvement in aerosol-generating airway interventions. This has caused the slow adoption of laryngeal masks during the pandemic. Various anesthetic guidelines have emerged due to coronavirus outbreak; underlying management principles include protecting healthcare workers and minimizing aerosol contamination.

Laryngeal Mask Market Segmentation

Grand View Research has segmented the global laryngeal mask market on the basis of type, patient, end-use, and region:

Based on the Type Insights, the market is segmented into Reusable and Disposable

• The disposable type segment dominated the market for laryngeal masks and accounted for the largest revenue share of over 57.5% in 2020 owing to associated benefits with its usage.
• The reusable type segment is anticipated to witness a lucrative CAGR of 5.3% over the forecast period.

Based on the Patient Insights, the market is segmented into Children, Adult, and Geriatric

• The adult patients segment dominated the laryngeal mask market and accounted for the largest revenue share of more than 58.8% in 2020.
• The segment will expand further at a steady CAGR on account of the increasing number of surgeries performed and the high prevalence of chronic diseases in adults.

Based on the End-use Insights, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers

• The hospitals and clinics segment held the maximum revenue share of over 60.3% in the market for laryngeal masks in 2020.
• The Ambulatory Surgical Centers (ASCs) segment is projected to register the fastest CAGR of 6.4% over the forecast period.

Laryngeal Mask Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Most of the companies have undertaken several business strategies, such as new product launches, strategic collaborations, and regional expansion, as emerging countries are still in the loop of adopting the product, to gain a competitive edge.

Some prominent players in the global Laryngeal Mask market include:

• Teleflex Incorporated
• Intersurgical Ltd
• Dynarex Corporation
• Medtronic, Ambu A/S
• Hitec Medical
• McKesson Corporation
• Thermo Fisher Scientific Inc.
• Anandic Medical Systems
• Narang Medical

Order a free sample PDF of the Laryngeal Mask Market Intelligence Study, published by Grand View Research.

Chemiluminescence Immunoassay Market Key Players are F. Hoffmann-La Roche and Beckman Coulter

Chemiluminescence Immunoassay Industry Overview

The global chemiluminescence immunoassay market size is expected to reach USD 13.75 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.9% from 2021 to 2028. The high prevalence of chronic diseases, several advantages of chemiluminescence immunoassay (CLIA) technique, and approval and launch of novel CLIA solutions are anticipated to be the major factors driving the market.

Key players in the market are implementing organic and inorganic growth strategies for the development, launch, and distribution of novel CLIA solutions. For instance, in February 2020, Snibe Diagnostic, a China-based immunoassay manufacturer, received CE marking for its new MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG CLIA kits. In another instance, in January 2018, DiaSorin partnered with Germany-based Qiagen and added Qiagen’s QuantiFERON-TB diagnostic test portfolio to its LIAISON family of fully automated chemiluminescence immunoassay analyzers. Such initiatives by major players are anticipated to significantly support the market growth. However, the high setup cost of automated chemiluminescence immunoassay systems is expected to be a major factor hindering the market growth.

Chemiluminescence Immunoassay Market Segmentation

Grand View Research has segmented the global chemiluminescence immunoassay market on the basis of product, application, end-use, and region:

Based on the Products Insights, the market is segmented into Instruments, Consumables, and Software & Services

• The consumables segment dominated the market with a share of over 65.0% in 2020 and is anticipated to maintain its lead over the forecast period owing to their high demand in therapeutic drug monitoring, endocrinology, and disease diagnosis
• The instruments segment is expected to witness considerable growth during the forecast period.

Based on the Application Insights, the market is segmented into Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease, and Others

• The infectious disease segment held the largest share of over 28.0% in 2020. This is attributed to the introduction of novel CLIA assays for the diagnosis of infectious diseases.
• e oncology segment is expected to witness significant growth over the forecast period. This growth is attributed to the high prevalence of cancer and increasing awareness about its early diagnosis in emerging economies.

Based on the End-use Insights, the market is segmented into Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, and Others

• Hospitals dominated the market in 2020 with a share of over 35.0%.
• The clinical laboratories segment accounted for a significant share in 2020. The growth of this segment can be attributed to cost-effective testing services offered by clinical laboratories.

Chemiluminescence Immunoassay Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Emerging players in the CLIA market are implementing inorganic growth strategies, such as strategic collaborations and partnerships, to gain an advantage over other players.

Some prominent players in the global Chemiluminescence Immunoassay market include:

• DiaSorin S.p.A.
• Abbott Laboratories
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Immunodiagnostic Systems
• Siemens Healthineers
• Beckman Coulter Inc.
• Hoffmann-La Roche AG
• Inova Diagnostics, Inc.
• Maccura Biotechnology Co., Ltd.
• Ortho Clinical Diagnostics

Order a free sample PDF of the Chemiluminescence Immunoassay Market Intelligence Study, published by Grand View Research.

Contrast Enhanced Ultrasound Market is boosted by Introduction of Affordable Contrast Agents, 2028

Contrast Enhanced Ultrasound Industry Overview

The global contrast enhanced ultrasound market size is estimated to reach USD 2.71 billion by 2028, expanding at a CAGR of 4.0%, according to a new report by Grand View Research, Inc. Introduction of affordable dyes, increasing sonography procedural volume, and contrast imaging modes becoming an integral feature of ultrasound systems are the prominent factors driving the market.

The increasing prevalence of cardiovascular diseases, liver lesions, renal lesions, gastrointestinal diseases, and vascular diseases globally is anticipated to boost the market growth, as these are major areas of clinical application of Contrast-enhanced Ultrasound (CEUS) systems.

Contrast Enhanced Ultrasound Market Segmentation

Grand View Research has segmented the global contrast-enhanced ultrasound market on the basis of product, type, end-use, and region:

Based on the Products Insights, the market is segmented into Equipment and Contrast Agent

• In 2020, the equipment segment dominated the product segment with a market share of 72.6%.
• The contrast agents segment is expected to grow at the fastest rate of 4.0% during the forecast period owing to its approval of usage in the liver and pediatric imaging by the FDA

Based on the Type Insights, the market is segmented into Non-targeted and Targeted

• In 2020, the non-targeted type segment dominated the CEUS market with a revenue share of over 73%.
• The increasing prevalence of chronic illnesses, such as liver cirrhosis, cancer, and CVDs, is the key factor expected to propel market growth.

Based on the End-use Insights, the market is segmented into Hospitals, Clinics, and Ambulatory Diagnostic Centers

• The hospitals segment dominated the market and accounted for the largest revenue share of more than 58% in 2020.
• The availability of specialist doctors and technicians in hospitals possessing skills in handling equipment & contrast agent is anticipated to fuel segment growth over the forecast years.

Contrast Enhanced Ultrasound Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The key players are adopting various business strategies, such as mergers & acquisitions, product launches, joint ventures, and partnerships, to strengthen their presence in the global market.

Some prominent players in the global Contrast Enhanced Ultrasound market include:

• Lantheus Medical Imaging, Inc.
• Bracco Diagnostic Inc.
• General Electric
• Siemens Healthcare GmbH
• nanoPET Pharma GmbH
• ESAOTE SpA
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Order a free sample PDF of the Contrast Enhanced Ultrasound Market Intelligence Study, published by Grand View Research.

COVID-19 Detection Kits Market is driven by Ongoing Seroprevalence Surveys to Asses the Infection Rate

COVID-19 Detection Kits Industry Overview

The global COVID-19 detection kits market size is expected to reach USD 4.63 billion by 2027, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 5.05% during the forecast period. The COVID-19 pandemic has posed several challenges to the global healthcare systems. The diagnostics area is recognized as one of the primary elements of efforts to contain the spread and circumvent its adverse impact globally. As a result, companies are ramping up their production process to meet the demand or kits and reagents as well as at-home tests, thereby driving the market revenue.

Constantly increasing demand for rapid diagnostic tests that can deliver results in less time coupled with a shortage of testing materials has triggered the development of antibody and antigen test kits. For instance, in August 2020, Abbott Laboratories secured approval for a COVID-19 portable antigen test that can deliver results in 15 minutes.

COVID-19 Detection Kits Market Segmentation

Grand View Research has segmented the global COVID-19 detection kits market on the basis of product, sample type, mode, end-use, and region:

Based on the Products Insights, the market is segmented into RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes

• RT-PCR assay kits are estimated to account for the maximum revenue share of 67% in 2020.
• Immunoassays test strips are promising tools for the first-line diagnosis of COVID-19 during the ascendant phase of the pandemic and are anticipated to register the fastest growth rate.

Based on the Sample Type Insights, the market is segmented into Nasopharyngeal (NP) Swab, Oropharyngeal (OP) Swab, Nasal Swab, and Others

• Nasopharyngeal swabs (NP) are estimated to dominate the revenue share with more than 45% in 2020 owing to the high usage of NP swabs for molecular testing.
• Ongoing large scale geographic seroprevalence surveys to estimate the number of people infected with the SARS-CoV-2 but were not included in official case counts; boost the revenue growth in this segment.

Based on the Mode Insights, the market is segmented into Decentralized or Point-of-Care (PoC) Testing and Centralized Testing (Non-PoC)

• Detection kits for centralized or laboratory testing are currently dominating the COVID-19 detection kits market with a revenue share of around 68% in 2020.
• POC testing, such as rapid antigen tests, is relatively less reliable in terms of result accuracy owing to their low sensitivity.

Based on the End-use Insights, the market is segmented into Laboratories, Hospitals, Diagnostic Centers and Clinics, and Others (Research Institutes & Direct-to-Consumers)

• The laboratories segment is projected to account for a revenue share of 40% in 2020, resulting in its dominance over other counterpart segments.
• Diagnostic centers and clinics are projected to grow at the fastest CAGR during the forecast period due to numerous efforts undertaken by several entities.

COVID-19 Detection Kits Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Market participants are incessantly developing several types of kits for the detection of SARS-CoV-2 infection across the globe. Such new product development initiatives along with partnership and collaboration models, agreements, business expansion, and merger and acquisition strategies are undertaken by the company as a response to the rising demand for COVID-19 test capabilities globally. This is expected to intensify the competition among key participants in future market space.

Some prominent players in the global COVID-19 Detection Kits market include:

• Hoffman-La Roche Ltd.
• Thermo Fisher Scientific, Inc.
• Perkin Elmer, Inc.
• Veredus Laboratories
• DiaSorin
• altona Diagnostics GmbH
• Mylab Discovery Solutions Pvt Ltd
• Abbott
• Luminex Corporation
• Quidel Corporation
• Becton, Dickinson and Company

Order a free sample PDF of the COVID-19 Detection Kits Market Intelligence Study, published by Grand View Research.

CBD Pet Market is expected to expand at a CAGR of 58.9% by 2028

CBD Pet Industry Overview

The global CBD pet market size is expected to reach USD 4.79 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 58.9% from 2021 to 2028. Increasing health expenditure and growing health concerns among the owners of domesticated animals are driving the market. In addition, increasing demand for cannabidiol (CBD) infused food products is boosting the market growth. For instance, in 2019, Nestle owned Purina, a pet food company, broadcasted its decision to invest in CBD-infused dog food production. Furthermore, increased usage of natural supplements in treating various lifestyle-related disorders in domesticated animals is fueling the growth.

The Covid-19 pandemic has increased pet ownership, resulting in significant spending on pets. As per the APPA estimation, 11.4 million households got a new companion animal during the pandemic. As a result, an upsurge in the sales of pet supplements in 2020was partially a result of the flood of CBD supplements into the market to address issues comprising anxiety, pain management, and inflammation for their pets.

CBD Pet Market Segmentation

Grand View Research has segmented the global CBD pet market on the basis of animal type, indication, end use, and region:

Based on the Animal Type Insights, the market is segmented into Dog and Cat

• The dog segment dominated the market and accounted for a share of over 68.0% in 2020.
• The cat segment is expected to witness lucrative growth over the forecast period.

Based on the Indication Insights, the market is segmented into Joint Pain, Anxiety/Stress, Epilepsy, General Health/Wellness, and Others

• The general health/wellness segment dominated the market with a revenue share of over 23.0% in 2020.
• The joint pain accounted for the second-largest revenue share in 2020.

Based on the End-use Insights, the market is segmented into Hospitals, Ambulatory Surgery Centers, Pet Specialty Stores, E-commerce, CBD Store, and Others

• The e-commerce segment dominated the market and accounted for a revenue share of more than 40.0% in 2020.
• The growth can be attributed to the easy availability of various CBD products on online portals. The prescription-related complication can be avoided using an online platform.

CBD Pet Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The market is highly competitive. The pet food companies such as Nestle; Mars Inc.; and General Mills Inc. are also expected to enter into the market in the coming years by opting for strategies such as new product launches, acquisitions, and collaborations in order to increase their market penetration.

Some prominent players in the global CBD Pet market include:

• Honest Paws
• Canna-Pet
• Fomo Bones
• Pet Relief
• HolistaPet
• Joy Organics
• Wet Noses
• CBD Living
• Pet stock
• Petco
• Charlotte’s Web

Order a free sample PDF of the CBD Pet Market Intelligence Study, published by Grand View Research.

Vitrification Market is spurred by Social Acceptance of Fertility Preservation Techniques, 2027

Vitrification Industry Overview

The global vitrification market size is expected to reach USD 20.3 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 17.7% from 2021 to 2027. Several experiments and investigations have been conducted to prove the efficiency of vitrification over slow freezing, leading to its increased clinical implementation. Currently, most IVF clinics are using this method to freeze the eggs/embryos and deliver a higher success rate to patients, thereby driving the market.

Increasing infertility rates have significantly driven the fertility preservation space. Preserving biospecimens has become a common trend among consumers in order to avoid the subsequent consequences of delayed childbearing. Furthermore, increasing awareness of reproductive health has driven the attention of people towards the freezing of biospecimens. This has created commercial opportunities for players such as Vitrolife and IVF Store that are engaged in offering vitrification solutions for fertility preservation.

Vitrification Market Segmentation

Grand View Research has segmented the global vitrification market on the basis of specimen, end-use, region:

Based on the Specimen Insights, the market is segmented into Oocytes, Embryo, and Sperm

• Vitrification-based oocyte freezing accounted for the major revenue share of more than 40% in 2020.
• Embryo and oocyte freezing witnessed tremendous growth over the past years with the introduction of vitrification procedures, as it offers over an 85% success rate.

Based on the End-use Insights, the market is segmented into IVF Clinics and Biobanks

• The IVF clinics segment dominated the vitrification market and accounted for the largest revenue share of 59.0% in 2020 owing to the high usage rate of devices and consumables in these end-use settings.
• The presence of a substantial number of biobanks has facilitated the egg donation process. The banks offer databases of egg donors which further aids informed decision-making by the individuals seeking IVF from donor eggs. This is anticipated to positively accelerate the revenue share of biobanks in the market for vitrification.

Vitrification Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The presence of an extensive distribution network for widespread presence across multiple countries coupled with an extensive product portfolio has contributed to the wide presence of these companies. Companies have collaborated with distribution partners to expand their business footprint. Furthermore, emerging players in the market are trying to expand their geographical reach through mergers, collaborations, and co-marketing.

Some prominent players in the global Vitrification market include:

• Vitrolife
• IVF Store LLC
• Frozen Cell
• Cook Medical Inc
• Minitube
• IMV Technologies
• Coopersurgical Fertility And Genomic Solutions
• Fujifilm Irvine Scientific
• Biotech Inc.
• Kitazato Corporation

Order a free sample PDF of the Vitrification Market Intelligence Study, published by Grand View Research.

Anti-biofilm Wound Dressing Market Demand is Rising due to Growing Number of Ambulatory Surgery Centers, 2028

Anti-biofilm Wound Dressing Industry Overview

The global anti-biofilm wound dressing market size is expected to reach USD 1,219.85 million by 2028, expanding at a CAGR of 9.2%, according to a new report by Grand View Research, Inc. The rising incidence of Hospital Acquired Infections (HAIs), the growing prevalence of chronic diseases, and the increasing number of burn cases are the key driving factors for the market.

Increasing the prevalence of chronic diseases across the globe is anticipated to drive the market. For instance, as per the International Diabetes Federation, the global prevalence of diabetes is expected to increase from 366.0 million in 2011 to 552.0 million by 2030. Since prolonged diabetes leads to diabetic foot ulcers, thus, the rising prevalence of diabetes is expected to render a positive impact on market growth over the forecast period. The anti-biofilm wound dressing is very much effective in healing chronic injuries, thus, this factor is expected to propel the demand for the product. Furthermore, the increasing geriatric population across the globe is also anticipated to surge the market growth. For instance, as per the World Health Organization (WHO), the global geriatric population is anticipated to rise from 90.0 million in 2016 to 2.0 billion by 2050. Since the geriatric population is prone to chronic diseases and ulcers, thus growing geriatric population is also expected to surge in market growth.

Anti-biofilm Wound Dressing Market Segmentation

Grand View Research has segmented the global anti-biofilm wound dressing market on the basis of mode of mechanism, application, and region:

Based on the Mode of Mechanism Insights, the market is segmented into Physical, Chemical, and Biological

• The chemical mode of mechanism segment held the largest share of over 40.0% in 2020 and is anticipated to witness the fastest growth over the forecast period owing to the rising prevalence of chronic wounds and the increasing number of surgeries across the globe.
• The chemical segment is further fragmented into ionic silver, iodine, EDTA, and others.
• The presence of several players offering anti-biofilm wound dressing products with iodine and ionic silver is the major factor promoting the segment growth.

Based on the Application Insights, the market is segmented into Chronic Wounds and Acute Wounds

• The acute wounds segment held the largest share of over 55.0% in 2020 owing to the rising cases of burns and trauma and the increasing number of surgeries across the globe.
• The chronic wounds segment is anticipated to witness the fastest growth over the forecast period owing to the increasing cases of chronic diseases, especially diabetes, across the globe.

Anti-biofilm Wound Dressing Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Companies are focusing on research and development to develop technologically advanced products to gain a competitive edge.

Some prominent players in the global Anti-biofilm Wound Dressing market include:

• ConvaTec
• Smith & Nephew PLC
• Urgo Medical
• Coloplast
• 3M

Order a free sample PDF of the Anti-biofilm Wound Dressing Market Intelligence Study, published by Grand View Research.

Medical Supply Delivery Service Market is driven by Increasing Need for Quick Transportation During Emergencies, 2028

Medical Supply Delivery Service Industry Overview

The global medical supply delivery service market size is expected to reach USD 101.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.3% from 2021 to 2028. The growing need for ensuring quick, safe, and secure transportation of samples and specimens for testing, reducing logistics costs, and increasing focus on improving the healthcare system is increasing the demand for medical supply delivery services. The increasing incidence of road accidents owing to various factors leading to blood loss and immediate requirement for blood is boosting the market growth. Furthermore, the growing geriatric population, rising incidence of diabetes and hypertension, and the rising surgical procedures for organ transplants are driving the market growth.

The expansion of healthcare logistics and rising demand for faster and cost-effective delivery of samples and specimens for testing or diagnostic purposes is bolstering the market growth. The introduction of drone delivery services supports healthcare facilities to transport medical items at an unparalleled level of speed and predictability, resulting in increased operational savings and improved patient care. In addition, the introduction of small indoor drones that can deliver medicine to the bedside of a patient directly from the pharmacy while eliminating human interaction leading to more rapid and less error-prone administration of medications further drives the market.

Medical Supply Delivery Service Market Segmentation

Grand View Research, has segmented the global medical supply delivery service market based on application, mode of service, end-user, and region:

Based on the Application Insights, the market is segmented into Medical Supplies, Drug Supplies, Emergency Services, and Lab Specimens & Reports

• In 2020, medical supplies accounted for the largest share of over 30.0%.
• The lab specimens and reports application segment is anticipated to register the fastest growth rate during the forecast period.

Based on the Mode Of Service Insights, the market is segmented into Courier Delivery and Drone Delivery

• In 2020, courier delivery accounted for the largest share of over 95.0% due to the presence of various national and multinational courier companies in the market that provide real-time tracking and a cost-effective way to transport medical supplies to hospitals and medical laboratories.
• Drone delivery is anticipated to register the fastest growth rate during the forecast period.

Based on the End-user Insights, the market is segmented into Hospitals, Clinics, Laboratories, Pharmacies, Patients, and Others

• In 2020, pharmacies accounted for the largest share of over 20.0% due to the increasing benefits offered by these services to fulfill unmet needs of consumers by doorstep delivery of medical supplies that benefits them to avoid long pharmacy lines, COVID-19 disease spread, and human intervention.
• The patients segment is anticipated to register the fastest growth rate during the forecast period owing to the adoption of medical delivery services enabling vulnerable patients to receive medicines at their doorstep to avoid interaction with COVID-19 patients.

Medical Supply Delivery Service Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The companies are focusing on expanding their geographical reach and introducing newer, innovative solutions through various strategies, including partnerships, product launches, and collaborations, to support the endusers in faster delivery of medical supplies, deliver value-based care, combat the COVID-19 pandemic, and maintain a competitive edge in the market.

Some prominent players in the global Medical Supply Delivery Service market include:

• DHL International GmbH
• United Parcel Service of America, Inc.
• Agility
• ModivCare Solutions, LLC
• FedEx
• CEVA Logistics
• wingslogistics
• International SOS
• Matternet
• Zipline
• Flirtey
• Swoop Aero

Order a free sample PDF of the Medical Supply Delivery Service Market Intelligence Study, published by Grand View Research.

Key Players Operating in The Fusion Biopsy Market Include MedCom, ESAOTE SPA, and GeoScan Medical

Fusion Biopsy Industry Overview

The global fusion biopsy market size is estimated to reach USD 1.11 billion by 2028 registering a CAGR of 11.6%, according to a new report by Grand View Research, Inc. The increasing prevalence of prostate cancer, growing demand for targeted biopsy, and the rising utilization rate of multiparametric MRI in prostate cancer care are factors expected to drive the market during the forecast period.

High sensitivity and specificity of targeted MR/Ultrasound fusion biopsy in delineating prostate lesions compared to other traditional technologies such as TRUS biopsy, PSA test, or Digital Rectal Examination is expected to contribute to the market growth. The reliability and reproducibility of the fusion biopsy system in the diagnosis of aggressive tumors is expected to make it a standard tool in prostate biopsy.

Fusion Biopsy Market Segmentation

Grand View Research has segmented the global fusion biopsy market on the basis of biopsy route, end-use, and region:

Based on the Route Insights, the market is segmented into Transrectal and Transperineal

• The transrectal segment dominated the market for fusion biopsy and accounted for the largest revenue share of 86.7% in 2020 because it was considered as the gold standard in performing prostate biopsy worldwide in the past decades.
• Transperineal fusion biopsy is an emerging trend and is expected to experience the fastest CAGR of 15.2% during the forecast period.

Based on the End-use Insights, the market is segmented into Hospitals, Diagnostic Centers, and Ambulatory Care Centers

• The hospitals segment dominated the market for fusion biopsy and held the largest revenue share of 61.0% in 2020 owing to their high purchasing power.
• The diagnostics centers segment is expected to grow at a significant rate in the market for fusion biopsy over the forecast period.
• The ambulatory care centers segment is expected to grow at the fastest rate of 12.6% during the forecast period.

Fusion Biopsy Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The market for fusion biopsy is decently fragmented, with the top few players holding the majority of the share. However, increasing demand for efficient diagnostic tools in prostate cancer management is creating growth opportunities for new players to enter the market.

Some prominent players in the global Fusion Biopsy market include:

• MedCom
• ESAOTE SPA
• KOELIS
• Focal Healthcare
• GeoScan Medical
• UC-Care Medical Systems Ltd.

Order a free sample PDF of the Fusion Biopsy Market Intelligence Study, published by Grand View Research.

COVID-19 Clinical Trials Market Penetration and Growth Prospect Mapping, 2027

COVID-19 Clinical Trials Industry Overview

The global COVID-19 clinical trials market size is expected to reach USD 9.9 billion by 2027, registering a CAGR of 9.5% during the forecast period, according to a new report by Grand View Research, Inc. An increasing number of deaths due to coronavirus is creating a need to develop effective treatments, thereby boosting the market growth. Also, the underlying economic profits for first movers are encouraging pharmaceutical players to invest in clinical trial studies for COVID-19.

The current pandemic poses an acute health risk to the entire population. A key to successfully fighting COVID-19 lies in clinical research. At present, almost all the major research-based pharmaceutical companies, many other biotechnology and pharmaceutical companies, as well as research institutes are engaged in a race to develop an effective treatment against coronavirus. There are currently 661 unique compounds in development against COVID-19, of which 292 are drugs, 173 are vaccines and 196 are antivirals. Factors such as globalization of clinical trials, demand for CROs to conduct clinical trials, and technological evolution, are further anticipated to drive growth.

COVID-19 Clinical Trials Market Segmentation

Grand View Research has segmented the global COVID-19 clinical trials market based on phase, product, and region:

Based on the Phase Insights, the market is segmented into Phase I, Phase II, Phase III, Phase IV, and Others

• The Phase II segment accounted for the largest market share in 2020, it contributed to 30.3% of the global COVID-19 clinical trials market in 2020.
• This is attributed to the fact that the maximum number of therapeutics and vaccines in development are in Phase II.

Based on the Product Insights, the market is segmented into Therapeutics and Vaccines

• The vaccines segment held the largest market share of over 75% as of 2020. This is mainly due to the huge investments in the development of vaccines.
• The therapeutic segment is projected to witness the fastest CAGR of 10.0% over the forecast period. The growth is attributed to a large number of therapeutics are in development as compared to vaccines.

COVID-19 Clinical Trials Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The key players are often involved in collaborations and partnerships to accelerate the production of vaccines and drugs against coronavirus.

Some prominent players in the global COVID-19 Clinical Trials market include:

• Moderna, Inc.
• GlaxoSmithKline plc
• Pfizer Inc.
• Johnson & Johnson
• Gilead Sciences Inc.
• INOVIO Pharmaceuticals
• AbbVie Inc.
• BioNTech SE
• Novavax
• Takeda

Order a free sample PDF of the COVID-19 Clinical Trials Market Intelligence Study, published by Grand View Research.

Preparative and Process Chromatography Market is driven by Growing Use of Chromatography Techniques

Preparative and Process Chromatography Industry Overview

The global preparative and process chromatography market size is expected to reach USD 17.26 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.65% from 2021 to 2028. High demand for monoclonal antibodies, coupled with the growing adoption of preparative chromatographic techniques in the bioprocessing industry, is anticipated to boost the revenue growth in the market over the forecast period.

Moreover, an increase in the number of R&D activities in the pharmaceutical and biotechnology industries is driving the adoption of liquid chromatographic techniques in downstream assays, resulting in the anticipated market growth. In addition, technological developments to advance the final product recovery in terms of yield accelerate and augment the uptake of these techniques across various applications.

Preparative and Process Chromatography Market Segmentation

Grand View Research has segmented the global preparative and process chromatography market on the basis of product, type, end use, and region:

Based on the Product Insights, the market is segmented into Process Chromatography and Preparative Chromatography

• Process chromatography captured the largest share of over 55.0% in 2020. These systems are widely used in industries for diverse biomolecule purifications.
• Preparative chromatography is estimated to expand at the fastest CAGR throughout the forecast period owing to its accurate and precise results.

Based on the Type Insights, the market is segmented into Liquid Chromatography, Gas Chromatography, Thin Layer Chromatography, Paper Chromatography, Gel-permeation (Molecular Sieve) Chromatography, and Hydrophobic Interaction Chromatography

• The liquid chromatography segment accounted for the largest share of 28.11% in 2020 owing to the widespread application across several industries.
• Depending upon the type, some major preparative and process chromatographic techniques include liquid chromatography (LC), HPLC, and gas chromatography.
• The hydrophobic interaction chromatography segment is expected to witness the fastest growth throughout the forecast period.

Based on the End-use Insights, the market is segmented into Pharmaceutical, Biotechnology, Food, Nutraceutical, and Others

• The pharmaceutical segment accounted for the largest share of 42.64% in 2020 owing to the high usage of preparative and process chromatography in drug safety assessment.
• The food segment is expected to witness significant growth over the forecast period owing to the increasing concerns associated with food.

Preparative and Process Chromatography Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Companies engaged in the development of innovative products are expected to intensify the market competition. Companies are focusing on continuous innovations and launching products to retain and acquire market share.

Some prominent players in the global Preparative and Process Chromatography market include:

• GE Healthcare
• Agilent Technologies
• Danaher Corporation
• Bio-Rad Laboratories Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Shimadzu Corporation
• Novasep Holding S.A.S
• Waters Corporation

Order a free sample PDF of the Preparative And Process Chromatography Market Intelligence Study, published by Grand View Research.

COVID-19 Drug Delivery Devices Market Revenue Driver Analysis Report by 2027

COVID-19 Drug Delivery Devices Industry Overview

The global COVID-19 drug delivery devices market size is expected to reach USD 2.15 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% from 2022 to 2027. The market is expected to gain significant traction over the forecast period as various nasal drug delivery technologies for administrating COVID-19 vaccines are under clinical and pre-clinical development. For instance, in April 2020, Verndari, Inc. initiated the preclinical trials for coronavirus vaccine using its patented microneedle array dermal patch- VaxiPatch.

The nasal, dermal, and needle-free are alternatives to the traditional syringe vaccine platforms. These devices potentially reduce or eliminate needlestick injuries and reduce the associated treatment costs. According to the research article published in PLUS ONE Journal, November 2019, needlestick injury (NSI) is among a major burden in medical settings, leading to the transmission of infectious diseases, such as hepatitis and HIV.

COVID-19 Drug Delivery Devices Market Segmentation

Grand View Research has segmented the global COVID-19 drug delivery devices market based on the product, route of administration, distribution channel, and region:

Based on the Product Insights, the market is segmented into Prefilled Syringe, Needle-free Injectors, Inhalers, and Patch

• The prefilled syringe segment is expected to account for the largest revenue share of 64.6% in 2021 as several efforts are put up by the government organizations to ramp up prefilled syringe production.
• The developers are focused on developing novel drug delivery platforms for use in resource-constrained settings, thus accelerating the growth of nasal drug delivery devices.

Based on the Route of Administration Insights, the market is segmented into Parenteral, Nasal, and Dermal

• The parenteral segment is expected to capture more than 60.0% share of the overall revenue in 2021 and is anticipated to maintain its lead over the forecast period.
• Currently, about 10 potential COVID-19 vaccine candidates have entered the clinical trials, most of which are to be administered via a parenteral route of administration.
• The nasal segment is anticipated to witness significant growth over the forecast period as the drug and vaccine manufacturers are focused on developing vaccines, which would reduce storage and administration costs.

Based on the Distribution Channel Insights, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

• The hospital pharmacies segment is expected to account for the largest market share of 57.3% in 2021 as these drug delivery devices require medical assistance for vaccine administration.
• The online pharmacies segment is expected to expand at the highest CAGR of 14.4% from 2022 to 2027 and is anticipated to maintain its lead over the forecast period.

COVID-19 Drug Delivery Devices Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Market players are adopting several strategies such as acquisitions to intensify the product portfolio and for geographical expansion, significant investment in research and development, and product launch and innovation to gain a significant share in the global market.

Some prominent players in the global COVID-19 Drug Delivery Devices market include:

• AstraZeneca
• Johnson & Johnson
• Serum Institute of India
• GlaxoSmithKline plc
• Moderna
• Bharat Biotech
• Pfizer
• PharmaJet
• Novawax, Inc.

Order a free sample PDF of the COVID-19 Drug Delivery Devices Market Intelligence Study, published by Grand View Research.

U.S. Hospital Gowns Market to Witness Significant Growth Owing to The Increasing Prevalence of Chronic Diseases

U.S. Hospital Gowns Industry Overview

The U.S. hospital gowns market size is expected to reach USD 2.47 billion by 2028, expanding at a CAGR of 11.90%, according to a new report by Grand View Research, Inc. The rising incidence of Hospital Acquired Infections (HAIs), the impact of the COVID-19 outbreak, and the increasing number of surgical procedures are the key factors driving the market growth.

The recent outbreak of COVID-19 is anticipated to significantly impact the product demand. The pandemic, caused by the virus SARS-CoV-2, has drastically increased the demand for medicines, emergency supplies, and hospital equipment including gowns, antiseptics, and disinfectant products. The COVID-19 outbreak and increasing hospital admissions across the globe have significantly increased the demand for hospital gowns in the U.S. For instance, according to a report published by the World Health Organization (WHO) in April 2020, there were more than 723,605 existing cases and more than 28,252 new confirmed cases in the U.S. Furthermore, in order to meet the large demand for hospital gowns in the country, Ford has started manufacturing hospital gowns out of airbag materials. Therefore, the market is anticipated to grow at a considerable pace over the forecast period.

U.S. Hospital Gowns Market Segmentation

Grand View Research has segmented the U.S. hospital gowns market on the basis of type, usability, and risk type:

Based on the Type Insights, the market is segmented into Surgical Gowns, Non-surgical Gowns, and Patient Gowns

• Surgical gowns held the largest share of over 55.0% in 2020 and are anticipated to maintain their lead over the forecast period owing to the increasing number of surgeries in the U.S.
• The patient gowns segment is expected to expand at a CAGR of 12.2% during the forecast period.

Based on the Usability Insights, the market is segmented into Disposable Gowns and Reusable Gowns

• Disposable gowns held the largest share of more than 85.0% in 2020 and are expected to witness considerable growth over the forecast period, as their use can significantly reduce the risk of spreading diseases between patients.
• Disposable hospital gowns are segmented into low, average, and premium prices.
• Technological advancements in the healthcare sector are anticipated to contribute to the high growth of the reusable hospital gowns segment.

Based on the Risk Type Insights, the market is segmented into Minimal, Low, Moderate, and High

• High-risk hospital gowns held the largest share of over 25.0% in 2020.
• Minimal risk hospital gowns held the second-largest share in 2020 and are anticipated to witness the fastest growth over the forecast period owing to the presence of a large number of patients suffering from various non-communicable diseases.

Key Companies Profile & Market Share Insights

The market players are adopting various strategies, such as mergers & acquisitions, partnerships, and product launches, to strengthen their foothold in the market.

Some prominent players in the U.S. Hospital Gowns market include:

• Medline Industries, Inc.
• Standard Textile Co., Inc.
• Angelica
• AmeriPride Services Inc.
• 3M
• Cardinal Health

Order a free sample PDF of the U.S. Hospital Gowns Market Intelligence Study, published by Grand View Research.

Blood Transfusion Diagnostics Market growth is driven by Increasing Prevalence of Chronic Diseases

Blood Transfusion Diagnostics Industry Overview

The global blood transfusion diagnostics market size is expected to reach USD 5.8 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.6% from 2021 to 2027. The growing prevalence of chronic diseases coupled with increasing demand for disease screening is significantly driving the market growth.

Some of the chronic infectious diseases such as hepatitis B, hepatitis C, HIV, and syphilis create the need for accurate donor screening, further driving the market growth. There is an increasing risk of Transfusion-transmitted Infections (TTIs) that has led to high demand for donor screening. In order to prevent patients from unsuitable blood and blood products and combat TTIs, the need for donor screening is increasing.

Blood Transfusion Diagnostics Market Segmentation

Grand View Research has segmented the global blood transfusion diagnostics market on the basis of product, application, end use, and region:

Based on the Product Type Insights, the market is segmented into Reagents & Kits, Instruments, and Others

• In 2020, the reagents and kits segment dominated the market for blood transfusion diagnostics and accounted for the largest revenue share of 65.8%.
• Easy availability of products and repetitive purchase of these products required to screen both donor and recipient samples have majorly driven the segment growth.

Based on the Application Insights, the market is segmented into Blood Grouping and Disease Screening

• The disease screening segment dominated the market for blood transfusion diagnostics and accounted for the largest revenue share of 60.0% in 2020.
• The blood grouping segment is expected to hold a significant revenue share during the study period.

Based on the End-use Insights, the market is segmented into Hospitals, Blood Banks, Diagnostic Laboratories, and Others

• The blood banks segment dominated the market for blood transfusion diagnostics and accounted for the largest revenue share of 38.9% in 2020.
• This is due to a large number of disease screening and blood typing services performed before transfusion therapy.

Blood Transfusion Diagnostics Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The market is gaining considerable attention from several companies and regulatory authorities. Companies in this market are continuously undertaking various strategic initiatives to accelerate the development and manufacture of diagnostic tests for blood in turn gaining a competitive edge over others.

Some prominent players in the global Blood Transfusion Diagnostics market include:

• Immucor, Inc.
• Abbott
• Ortho Clinical Diagnostics
• Bio-Rad Laboratories
• Quotient Limited
• Hoffmann-La Roche AG
• DiaSorin S.P.A.
• BAG Healthcare GmbH
• Danaher
• BIOKIT (Werfen)

Order a free sample PDF of the Blood Transfusion Diagnostics Market Intelligence Study, published by Grand View Research.

Key Factors Contributing to Hernia Repair Devices Market Growth Include Favorable Reimbursement Policies, 2028

Hernia Repair Devices Industry Overview

The global hernia repair devices market size is expected to reach USD 7.21 billion by 2028, registering a CAGR of 5.65% over the forecast period, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing prevalence of obesity and hernia globally. Being overweight causes the pressure and strain on abdominal muscles and makes them prone to development of the disease. Moreover, technological advancements and several product launches in the field of repair devices are further augmenting the growth.

Factors contributing to the growth include sedentary lifestyle, obesity, large weight loss, poor diet, chronic cough, and pregnancy. Furthermore, favorable reimbursement policies and FDA approvals of various repair devices are encouraging patients to opt for open or laparoscopy surgery. According to NCBI Report, more than 20.0 million hernia repair procedures are performed each year globally. The surgical procedure is an important revenue stream for hospitals, estimated at USD 48.0 billion per year in U.S.

Hernia Repair Devices Market Segmentation

Grand View Research has segmented the global hernia repair devices market on the basis of product type, surgery type, procedure type, and region:

Based on the Product Type Insights, the market is segmented into Hernia Mesh and Hernia Fixation Devices

• The hernia mesh segment dominated the market with a revenue share of 76.1% in 2020 owing to the wide adoption of these devices.
• The hernia fixation devices segment is expected to expand at the fastest CAGR in terms of revenue during the forecast period.

Based on the Surgery Type Insights, the market is segmented into Inguinal Hernia, Umbilical Hernia, Incisional Hernia, Femoral Hernia, and Others

• Inguinal hernia dominated the market with a revenue share of over 65.0% in 2020.
• The incisional hernia segment is expected to expand at the fastest CAGR in terms of revenue during the forecast period.

Based on the Procedure Type Insights, the market is segmented into Open Surgery and Laparoscopic Surgery

• Open surgery dominated the market with a revenue share of 76.3% in 2020 and is expected to maintain its lead throughout the forecast period owing to its benefits such as the low cost of the procedure and fewer post-operative complications.
• Laparoscopic surgery is expected to register the fastest growth rate in terms of revenue over the forecast period as it is widely accepted as a hernia treatment option.

Hernia Repair Devices Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The market has been characterized by high competition owing to the presence of established players operating in the market. Thus, to maintain a greater market share, many large companies are coexisting with companies that specialize in a particular product line.

Some prominent players in the global Hernia Repair Devices market include:

• B Braun Melsungen AG
• Cook Medical
• Medtronic Plc
• L. Gore & Associates
• Ethicon Inc.
• R Bard Inc
• Atrium
• LifeCell Corporation
• Baxter International
• Herniamesh S.R.L.

Order a free sample PDF of the Hernia Repair Devices Market Intelligence Study, published by Grand View Research.

Demand for Endotracheal Tube Market is Increasing Owing to Rising Number of Surgical Procedures, 2028

Endotracheal Tube Industry Overview

The global endotracheal tube market size is expected to reach USD 3.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2021 to 2028. Endotracheal tubes are used to supply oxygen or other gases to the lungs. The rising prevalence of chronic diseases such as respiratory, cardiovascular diseases, and an increasing number of surgical procedures, are expected to propel market growth. In addition, technological development pertaining to endotracheal tubes is further expected to contribute to significant market activities during the forecast period. Recently, Medtronic has launched a Shiley laser oral endotracheal tubes that are most widely used for ventilation during CO2 and Potassium Titanyl Phosphate (KTP) laser surgeries of the laryngeal or tracheal area.

Certain key factors contributing towards market revenue are the growing need for ventilator-associated with pneumonia and increasing geriatric population that are prone to chronic diseases. Recently increasing occurrence of Ventilator-associated Pneumonia (VAP) is most widely seen in patients who are on the endotracheal tube or mechanical ventilator for more than 48 hours. Thus, many players in the market are developing products with antimicrobial coating and anti-coagulant coating properties which can reduce VAP. With opportunities existing, manufacturers are investing in increasing awareness about the technologically advanced endotracheal tube. For instance, and developments in the field of nanobiotechnology and drug design are spaces that may exhibit higher activities for market growth.

Endotracheal Tube Market Segmentation

Grand View Research has segmented the global endotracheal tubes market based on product type, route type, application, end-use, and region:

Based on the Product Type Insights, the market is segmented into Regular, Reinforced, Preformed, and Double lumen

• The regular endotracheal tube segment dominated the market and held the largest revenue share of 32.0% in 2020 due to the increasing number of surgical procedures owing to the increasing prevalence of respiratory diseases.
• However, the reinforced endotracheal tube segment is anticipated to witness higher growth over the forecast period owing to its rising use during the surgery, and also due to recent technological development made in endotracheal tube.

Based on the Route Type Insights, the market is segmented into Orotracheal and Nasotracheal

• The orotracheal segment dominated the market and held the largest revenue share of 64.9% in 2020.
• The nasotracheal segment is anticipated to witness the fastest CAGR of 5.6% over the forecast period owing to the increase in the prevalence of the respiratory disease.

Based on the Application Insights, the market is segmented into Emergency Treatment, Therapy, and Others

• The emergency treatment segment dominated the market and held the largest revenue share of 55.5% in 2020.
• However, the therapy segment is expected to show higher growth during forecast period.

Based on the End-use Insights, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Others

• The hospitals segment held the largest revenue share of over 34.3% in 2020 owing to the increasing trend of hospitalization worldwide.
• The clinics segment is expected to observe the highest growth over the forecast period.
• However, ambulatory surgical centers are also expected to show significant growth during the forecast period due to its increasing centers in North America and Asia Pacific.

Endotracheal Tube Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Key parameter affecting the competitive nature of the market is the rapid adoption of advanced healthcare technology for improved healthcare. Also, to retain market share and diversify the product portfolio, major players are often undertaking mergers and acquisitions along with new product launches.

Some prominent players in the global Endotracheal Tube market include:

• Teleflex Corporation
• Medtronic
• Medline Industries
• Venner Medical
• Sonoma Pharmaceutical
• Hospiteknik Healthcare
• Armstrong Medical
• Airway Innovations
• Smiths Group
• ConvaTec, Inc.

Order a free sample PDF of the Endotracheal Tube Market Intelligence Study, published by Grand View Research.